Kim, Hae Jin
Hur, Kyu Yeon
Lee, Yong-Ho
Kim, Jin Taek
Lee, Yong-Kyu
Baek, Ki-Hyun
Choi, Euy Jin
Hwang, Won Min
Bang, Ki Tae
Lim, Jung Soo
Chung, Yun Jae
Jo, Sung Rae
Oh, Joon Seok
Lee, Soon Hee
Ko, Seung-Hyun
Choi, Sung Hee http://orcid.org/0000-0003-0740-8116
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effect of Pravastatin on Kidney Function in Patients with Dyslipidemia and Type 2 Diabetes Mellitus: A Multicenter Prospective Observational Study
https://doi.org/10.1007/s12325-024-02862-5
Funding for this research was provided by:
Daiichisankyo, Korea
Seoul National University
Article History
Received: 9 January 2024
Accepted: 27 March 2024
First Online: 16 June 2024
Declarations
:
: Hae Jin Kim, Kyu Yeon Hur, Yong-Ho Lee, Jin Taek Kim, Yong-Kyu Lee, Ki-Hyun Baek, Euy Jin Choi, Won Min Hwang, Ki Tae Bang, Jung Soo Lim, Yun Jae Chung, Sung Rae Jo, Joon Seok Oh, Soon Hee Lee, Seung-Hyun Ko, and Sung Hee Choi declare that they have no competing interests.
: The study protocol and informed consent forms were approved by the institutional review board (IRB) of each participating institution, including Seoul National University Bundang Hospital, Republic of Korea: study No. B-1511-322-305 (detailed for each institution in Table ). The study was registered with Clinicaltrials.gov (NCT05107063). The study was conducted in accordance with the principles of the Declaration of Helsinki 1964 and its later amendments, as well as the rules of each IRB. All patients voluntarily provided written informed consent before enrollment in the study. Data were de-identified to protect the privacy of the participating patients and to be fully compliant with locally applicable regulations.